It reaches the joint within 2 hours.2 Based on dose titration studies, clinical improvement may be observed by the fourth injection.3 Consult your veterinarian if you have any questions.
Adequan i.m. is an FDA-approved drug for the treatment of degenerative joint disease (DJD) and traumatic joint dysfunction. As required by FDA, safety and efficacy studies were conducted on Adequan i.m. without the concomitant use of additional products. Adequan i.m. successfully achieved FDA approval without use of additional oral joint health (OJS) products.1 Please talk to your veterinarian about treatment-specific questions for your horse.
There are many supplements, medical devices and over-the-counter products making claims similar to Adequan i.m. However, most of these products are only supported by testimonial statements and do not have the structured and qualified product testing and trials Adequan i.m. completed to obtain FDA approval.